UBLITUXIMAB AND IBRUTINIB FOR PREVIOUSLY TREATED GENETICALLY HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF THE GENUINE PHASE 3 STUDY
Sharman, J.P., Brander, D.M., Mato, A., Kambhampati, S., Burke, J.M., Lansigan, F., Schreeder, M.T., Lunin, S.D., Ghosh, N., Zweibach, A., Shtivelband, M.I., Travis, P.M., Chandler, J., Kolibaba, K.S.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_100
Date:
June, 2017
File:
PDF, 89 KB
english, 2017